Brigham and Women's Hospital: Neoplasms trials

The registry lists 11 Neoplasms studies with Brigham and Women's Hospital as lead sponsor. 4 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 2Phase 3 2Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Statins to Prevent Cancer Associated Blood ClotsRecruitingNCT07303816Phase 4
• Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated ProteinuriaRecruitingNCT07224776Phase 1
• Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a BiorepositoryRecruitingNCT06789601Phase 1/2
• Second Uterine Evacuation for Low-risk Gestational Trophoblastic NeoplasiaRecruitingNCT04756713Phase 3
• Positive Psychology Intervention In HSCTCompletedNCT05147311Not applicableResults posted
• COcoa Supplement and Multivitamin Outcomes StudyCompletedNCT02422745Phase 4Results posted
• Vitamin D and Omega-3 Trial (VITAL)Active, not recruitingNCT01169259Phase 3Results posted
• A Multilevel Intervention to Improve Timely Cancer Detection and Treatment InitiationActive, not recruitingNCT04141449Phase 2
• Augmented Reality Headset as Adjunct Display Monitor in AMIGOWithdrawnNCT03328416Not applicable
• Promoting Respect and Ongoing Safety Through Patient-centeredness, Engagement, Communication and TechnologyCompletedNCT02258594Not applicable
• Magnetic Resonance Imaging Guided Gynecologic BrachytherapyCompletedNCT00112307Not applicable